# AATD Treatment Options Guide

**Document Version**: 1.0
**Last Updated**: November 7, 2025
**Owner**: Medical Director
**Purpose**: Comprehensive guide to all available AATD treatments

---

## üìã Table of Contents

1. [Treatment Overview](#treatment-overview)
2. [Augmentation Therapy](#augmentation-therapy)
3. [Standard COPD Management](#standard-copd-management)
4. [Liver Disease Treatment](#liver-disease-treatment)
5. [Oxygen Therapy](#oxygen-therapy)
6. [Pulmonary Rehabilitation](#pulmonary-rehabilitation)
7. [Lung Transplantation](#lung-transplantation)
8. [Liver Transplantation](#liver-transplantation)
9. [Lifestyle Interventions](#lifestyle-interventions)
10. [Emerging Treatments & Clinical Trials](#emerging-treatments--clinical-trials)
11. [Treatment Decision Guide](#treatment-decision-guide)
12. [Insurance & Financial Assistance](#insurance--financial-assistance)

---

## Treatment Overview

### The Good News

**AATD is treatable**:

- Augmentation therapy slows lung disease progression
- COPD medications relieve symptoms
- Lifestyle changes make significant impact
- Transplantation available for advanced disease
- New treatments in clinical trials

**Goals of treatment**:

- ‚úÖ Slow disease progression
- ‚úÖ Relieve symptoms (shortness of breath, cough)
- ‚úÖ Prevent exacerbations (flare-ups)
- ‚úÖ Improve quality of life
- ‚úÖ Extend life expectancy

---

### Treatment Approach by Genotype

**ZZ Genotype (Severe AATD)**:

- Augmentation therapy (if lung disease present or preventive)
- COPD medications
- Pulmonary rehabilitation
- Lifestyle modifications
- Regular monitoring

**SZ Genotype (Moderate AATD)**:

- Case-by-case (may qualify for augmentation therapy)
- COPD medications
- Lifestyle modifications
- Monitoring

**MZ/MS Genotype (Carrier)**:

- Usually no specific AATD treatment needed
- Standard COPD management (if symptoms present)
- Focus on prevention (don't smoke, avoid irritants)
- Monitoring

---

## Augmentation Therapy

### What Is Augmentation Therapy?

**Also called**: Alpha-1 proteinase inhibitor therapy, AAT replacement therapy

**What it is**:

- Weekly IV infusions of purified AAT protein
- Derived from donated human blood plasma
- Raises AAT levels in blood and lungs
- Slows progression of lung disease

**The only treatment that addresses root cause of AATD lung disease**

---

### How It Works

**Normal AAT protects lungs**:

- Neutrophil elastase (enzyme) breaks down lung tissue
- AAT protein blocks neutrophil elastase
- In AATD: Not enough AAT ‚Üí unchecked elastase ‚Üí emphysema

**Augmentation therapy**:

- Infuses AAT protein ‚Üí raises blood level
- AAT reaches lungs ‚Üí protects from elastase damage
- Slows emphysema progression

**Does NOT cure AATD**: You still have genetic mutation, but treatment replaces missing protein

---

### Who Is Candidate for Augmentation Therapy?

**FDA-approved for**:

- Genotype ZZ, SZ, or other severe deficiency (AAT level <80 mg/dL)
- Evidence of lung disease (FEV1 between 30-80% predicted)

**American Thoracic Society guidelines**:

- AAT level <57 mg/dL (or <11 ¬µM)
- FEV1 <80% predicted
- Non-smoker or former smoker (quit at least 6 months ago)

**Off-label uses** (not FDA-approved but sometimes prescribed):

- Preventive (ZZ with normal lung function)
- Lung disease with FEV1 >80%
- MZ with significant lung disease

**NOT recommended if**:

- Currently smoking (must quit first)
- FEV1 <30% predicted (very severe disease, limited benefit)
- IgA deficiency (risk of allergic reaction)

---

### How Augmentation Therapy Is Given

**Frequency**: Once weekly

**Duration**: Typically 1-2 hours per infusion

**Location**:

- **Infusion center**: Hospital or clinic
- **Doctor's office**
- **Home infusion**: Nurse comes to you (preferred by many patients)

**Process**:

1. Check vital signs (blood pressure, pulse, temperature)
2. Insert IV catheter (usually in arm)
3. Infuse AAT over 1-2 hours
4. Monitor for reactions
5. Remove IV, apply bandage
6. Go home (no recovery time needed)

**For frequent IVs**: Some patients get port (permanent IV access in chest)

---

### Side Effects

**Common (mild)**:

- Headache
- Fatigue
- Dizziness
- Nausea
- Muscle aches
- Fever or chills

**Most side effects resolve quickly** (within 24 hours)

**Tips to minimize side effects**:

- Hydrate before and during infusion
- Take acetaminophen (Tylenol) or ibuprofen before infusion
- Slow infusion rate (discuss with nurse)
- Infuse at night (sleep through side effects)

**Rare but serious**:

- Allergic reaction (hives, difficulty breathing, swelling)
- Blood clots
- Infection from IV

**Call doctor if**:

- Severe allergic reaction
- Fever >101¬∞F
- Severe headache or chest pain

---

### Available Products

**Four FDA-approved augmentation therapy products** (all similar efficacy):

**1. Prolastin-C** (Grifols)

- Original AAT product
- Weekly IV infusion
- 60 mg/kg dose

**2. Zemaira** (CSL Behring)

- Weekly IV infusion
- 60 mg/kg dose

**3. Aralast NP** (Takeda)

- Weekly IV infusion
- 60 mg/kg dose

**4. Glassia** (Takeda)

- Weekly IV infusion
- 60 mg/kg dose

**All are equally effective**: Choice often based on insurance coverage, availability, or patient/doctor preference

---

### Does Augmentation Therapy Work?

**Evidence**:

- ‚úÖ Slows decline in lung function (FEV1)
- ‚úÖ Reduces frequency of exacerbations
- ‚úÖ May improve survival
- ‚úÖ Well-tolerated, safe

**What studies show**:

- Without augmentation: FEV1 declines ~50-100 mL/year
- With augmentation: FEV1 declines ~30-60 mL/year
- **~40% slower decline**

**Best results when started early** (before severe lung damage)

**Does NOT reverse existing damage**: Slows progression, doesn't heal damaged lungs

---

### Cost of Augmentation Therapy

**Expensive**: $100,000-$200,000 per year

**Good news**: Most patients pay very little out-of-pocket

**Insurance coverage**:

- Usually covered by commercial insurance, Medicare, Medicaid
- Requires prior authorization (doctor submits documentation)
- Co-pays vary ($0-$5,000 per year)

**Financial assistance** (see section below):

- Co-pay assistance programs (manufacturers)
- Patient assistance programs (free for uninsured)
- Mark Egly Foundation grants

**Don't let cost deter you**: Financial help is available

---

## Standard COPD Management

### Bronchodilators (Inhalers)

**What they do**: Relax airway muscles ‚Üí open airways ‚Üí easier breathing

**Types**:

**1. Short-Acting Bronchodilators (Rescue Inhalers)**:

- **Use**: During shortness of breath episodes
- **How fast they work**: 5-15 minutes
- **Duration**: 4-6 hours
- **Examples**:
  - Albuterol (ProAir, Ventolin, Proventil)
  - Levalbuterol (Xopenex)

**2. Long-Acting Bronchodilators (Maintenance Inhalers)**:

- **Use**: Daily to prevent symptoms
- **How fast they work**: 30 minutes to hours
- **Duration**: 12-24 hours
- **Examples**:
  - LABAs: Formoterol, salmeterol
  - LAMAs: Tiotropium (Spiriva), umeclidinium (Incruse)

**Often combined** with inhaled corticosteroids (see below)

---

### Inhaled Corticosteroids (ICS)

**What they do**: Reduce airway inflammation

**Use**: Daily (usually combined with bronchodilator)

**Examples**:

- Fluticasone (Flovent)
- Budesonide (Pulmicort)

**Combination inhalers** (LABA + ICS):

- Advair (fluticasone + salmeterol)
- Symbicort (budesonide + formoterol)
- Breo (fluticasone + vilanterol)

**Triple therapy** (LABA + LAMA + ICS):

- Trelegy (fluticasone + umeclidinium + vilanterol)
- Most effective for moderate-severe COPD

---

### Other Medications

**Oral Corticosteroids (Prednisone)**:

- **Use**: Short-term for exacerbations (flare-ups)
- **Duration**: 5-14 days
- **Side effects**: Weight gain, mood changes, high blood sugar, insomnia
- **Not for long-term use** (serious side effects)

**Antibiotics**:

- **Use**: Bacterial lung infections (exacerbations)
- **Common**: Azithromycin (Z-pack), amoxicillin, doxycycline
- **Keep on hand**: Many doctors prescribe "rescue pack" to start at first sign of infection

**Phosphodiesterase-4 Inhibitors**:

- **Roflumilast (Daliresp)**: Reduces inflammation, prevents exacerbations
- **Use**: Severe COPD with frequent exacerbations
- **Side effects**: Diarrhea, weight loss, nausea

**Mucolytics**:

- **Guaifenesin (Mucinex)**: Thins mucus, easier to cough up
- **N-acetylcysteine (NAC)**: Antioxidant, thins mucus
- **Hypertonic saline**: Nebulized salt water, loosens mucus

---

### Vaccinations

**Essential for AATD patients**:

‚úÖ **Flu vaccine**: Annually (every fall)

- Reduces risk of influenza (can trigger exacerbations)

‚úÖ **Pneumonia vaccines**:

- **Prevnar 20 (PCV20)**: One dose OR
- **Prevnar 15 (PCV15) + Pneumovax 23 (PPSV23)**: Two doses, 1 year apart
- Protects against pneumococcal pneumonia

‚úÖ **COVID-19 vaccine**: Per CDC recommendations (annual boosters)

‚úÖ **Tdap (Tetanus/Diphtheria/Pertussis)**: One dose, then Td booster every 10 years

- Pertussis (whooping cough) dangerous for COPD patients

‚úÖ **RSV vaccine**: For adults 60+ (Abrysvo or Arexvy)

- Respiratory syncytial virus causes severe lung infections

‚úÖ **Shingles vaccine (Shingrix)**: Age 50+

- Two doses, 2-6 months apart

**Ask your doctor**: "Am I up to date on all vaccines?"

---

## Liver Disease Treatment

### Monitoring

**If you have ZZ or SZ genotype**:

- Liver function tests (LFTs) annually
- If elevated ‚Üí refer to hepatologist

**Liver disease more common in**:

- Children (10-15% develop liver disease)
- Adults with obesity, diabetes, alcohol use

---

### Treatment for Liver Disease

**No specific medication for AATD liver disease**

**Management**:

- ‚úÖ Treat underlying causes (obesity, diabetes, alcohol)
- ‚úÖ Avoid hepatotoxic substances:
  - Alcohol
  - Acetaminophen (Tylenol) overuse
  - Certain medications
- ‚úÖ Get vaccinated (Hepatitis A, Hepatitis B)
- ‚úÖ Monitor for cirrhosis/liver cancer (ultrasound, blood tests)

**If cirrhosis develops**:

- Medications to manage complications (diuretics, beta blockers)
- Screening for liver cancer (ultrasound + AFP blood test every 6 months)
- Liver transplant evaluation (if liver failure)

---

### Liver Transplantation

**When needed**: End-stage liver disease, liver failure

**Outcomes**: Excellent

- Cures liver disease (but not lung disease‚Äîstill have AATD genotype)
- 5-year survival ~75-85%

**Transplanted liver makes normal AAT**: Some improvement in AAT levels (but usually not enough to prevent lung disease)

---

## Oxygen Therapy

### When Is Oxygen Needed?

**Oxygen prescribed if**:

- Resting oxygen saturation ‚â§88%
- Oxygen saturation drops during activity
- Oxygen saturation drops during sleep

**Measured with**: Pulse oximeter (clips on finger)

**Normal oxygen saturation**: ‚â•95%

---

### Types of Oxygen Systems

**1. Oxygen Concentrator (Home)**:

- Plugs into wall outlet
- Extracts oxygen from room air
- Unlimited supply
- Stationary (not portable)

**2. Portable Oxygen Concentrator (POC)**:

- Battery-powered
- Take anywhere (flights, errands, travel)
- More expensive
- Limited battery life (2-8 hours)

**3. Compressed Oxygen Tanks**:

- Small tanks for portability
- Limited supply (need refills)
- Heavier than POCs

**4. Liquid Oxygen**:

- Very cold liquid oxygen in tank
- Portable (refill from large home tank)
- Lasts longer than compressed tanks

---

### How to Use Oxygen

**Delivery**:

- Nasal cannula (plastic tubing in nostrils)
- Face mask (for higher flow rates)

**Flow rate**: Prescribed by doctor (e.g., "2 liters per minute")

- Don't adjust without doctor's permission

**When to use**:

- 24/7 (continuous)
- During activity
- During sleep
- As prescribed by doctor

**Don't skip oxygen**: Low oxygen damages organs (heart, brain)

---

### Oxygen Safety

**Oxygen is safe but flammable**:

- ‚ùå No smoking (you or others nearby)
- ‚ùå No open flames (candles, stoves, fireplaces)
- ‚ùå No sparks (grease, oil)
- ‚úÖ Keep oxygen ‚â•5 feet from heat sources
- ‚úÖ Post "Oxygen in Use" signs

---

## Pulmonary Rehabilitation

### What Is Pulmonary Rehab?

**Supervised exercise and education program** for people with chronic lung disease

**Components**:

- Exercise training (cardio, strength, flexibility)
- Breathing techniques
- Energy conservation strategies
- Nutritional counseling
- Emotional support
- Disease education

**Duration**: Typically 6-12 weeks, 2-3 sessions per week

**Where**: Hospital, clinic, or home (virtual programs available)

---

### Benefits of Pulmonary Rehab

**Evidence shows**:

- ‚úÖ Improves exercise tolerance
- ‚úÖ Reduces shortness of breath
- ‚úÖ Increases quality of life
- ‚úÖ Reduces hospitalizations
- ‚úÖ Improves mental health (less anxiety/depression)
- ‚úÖ Builds confidence and self-management skills

**One of most effective treatments for COPD/AATD**

---

### How to Access Pulmonary Rehab

**Step 1**: Ask your doctor for referral

**Step 2**: Insurance approval (usually covered)

**Step 3**: Schedule intake appointment

**Step 4**: Attend sessions (2-3 times per week)

**If you can't attend in-person**:

- Ask about home-based or virtual programs
- Some insurance covers

---

## Lung Transplantation

### When Is Lung Transplant Considered?

**End-stage lung disease**:

- FEV1 <25% predicted
- Severe shortness of breath at rest
- Frequent hospitalizations
- Oxygen-dependent
- Limited life expectancy without transplant

**AATD is common reason for lung transplant**: ~7% of all lung transplants

---

### Types of Lung Transplant

**1. Single Lung Transplant**:

- Replace one lung
- Shorter surgery, faster recovery
- Adequate for many AATD patients

**2. Double Lung Transplant**:

- Replace both lungs
- Better long-term outcomes
- More common for younger patients

---

### Transplant Process

**Step 1: Evaluation**:

- Extensive testing (lung function, CT scan, heart tests, blood work)
- Psychosocial evaluation
- Financial clearance
- Determine if suitable candidate

**Step 2: Wait List**:

- Added to national transplant waiting list (UNOS)
- Wait time: Months to years (depends on urgency, blood type, lung size)
- Lung allocation score (LAS) determines priority

**Step 3: Transplant Surgery**:

- Called when donor lungs available
- Must get to hospital within hours
- Surgery: 6-12 hours

**Step 4: Recovery**:

- ICU: 1-7 days
- Hospital: 2-3 weeks
- Rehab: 3-6 months

**Step 5: Lifelong Follow-Up**:

- Immunosuppressant medications (prevent rejection)
- Frequent monitoring (clinic visits, lung biopsies)
- Watch for rejection, infection

---

### Outcomes

**Success rates**:

- 1-year survival: ~90%
- 5-year survival: ~50-60%
- 10-year survival: ~30-35%

**Quality of life**: Dramatically improved

- Most patients feel much better
- Return to normal activities
- No longer need oxygen

**Transplant cures lung disease BUT**:

- Still have AATD genetics
- Transplanted lungs don't have AATD (donor lungs are normal)
- Liver disease (if present) not affected

---

## Liver Transplantation

### When Needed

**End-stage liver disease**:

- Cirrhosis with complications (ascites, bleeding, confusion)
- Liver cancer
- Liver failure

**Outcomes**: Excellent (see Liver Disease section above)

---

## Lifestyle Interventions

### Smoking Cessation

**THE MOST IMPORTANT THING YOU CAN DO**

**Smoking with AATD**:

- Lung function declines 10-15 years faster
- Emphysema develops earlier and more severely
- Augmentation therapy less effective

**If you smoke, QUIT NOW**:

- It's never too late (even with advanced disease, quitting helps)
- Lung function decline slows after quitting

**How to quit**:

- **Nicotine replacement**: Patches, gum, lozenges
- **Medications**: Bupropion (Zyban), varenicline (Chantix)
- **Counseling**: Quitline (1-800-QUIT-NOW)
- **Apps**: Smoke Free, QuitGuide
- **Mark Egly Foundation**: Smoking cessation support

**Don't give up**: Most people need 5-7 attempts before successfully quitting

---

### Avoid Lung Irritants

**What to avoid**:

- ‚ùå Secondhand smoke
- ‚ùå Vaping/e-cigarettes
- ‚ùå Air pollution (stay inside on high pollution days)
- ‚ùå Strong scents (perfumes, air fresheners, cleaning products)
- ‚ùå Dust (wear mask when cleaning)
- ‚ùå Mold
- ‚ùå Occupational exposures (chemicals, fumes, dust)

**Use HEPA air filters** at home

---

### Exercise

**Why exercise matters**:

- Improves lung function
- Strengthens muscles
- Boosts energy
- Slows disease progression

**How much**: 20-30 minutes, 3-5 times per week

**Types**:

- Walking, swimming, cycling
- Strength training (light weights)
- Flexibility (stretching, yoga)

**Start slowly, gradually increase**

---

### Nutrition

**Goals**:

- Maintain healthy weight
- Support immune system
- Preserve muscle mass

**What to eat**:

- Protein (lean meats, fish, beans)
- Fruits and vegetables (5+ servings per day)
- Whole grains
- Healthy fats (omega-3s)

**Stay hydrated**: 6-8 glasses of water daily

---

### Stress Management

**Chronic illness is stressful**

**Coping strategies**:

- Deep breathing exercises
- Meditation
- Yoga or tai chi
- Hobbies
- Therapy or counseling
- Support groups

---

## Emerging Treatments & Clinical Trials

### Gene Therapy

**Goal**: Fix SERPINA1 gene mutation

**Approaches**:

- Deliver healthy gene to liver cells
- Cells produce normal AAT protein

**Status**: Early clinical trials

- Phase 1/2 studies underway
- Promising results (AAT levels increased)
- Not yet FDA-approved

**Could be curative** in future

---

### Inhaled Augmentation Therapy

**Goal**: Deliver AAT directly to lungs (instead of IV infusion)

**Benefits**:

- Easier (inhale instead of IV)
- More convenient
- Higher AAT levels in lungs

**Status**: Clinical trials (Phase 2/3)

---

### Other Emerging Treatments

**1. Neutrophil Elastase Inhibitors**:

- Block elastase enzyme (different approach than AAT replacement)
- Several drugs in development

**2. Gene Editing (CRISPR)**:

- Correct genetic mutation in liver cells
- Very early research

**3. Stem Cell Therapy**:

- Repair damaged lung tissue
- Experimental

**4. AAT from Recombinant Sources**:

- Lab-produced AAT (instead of donated blood plasma)
- Potentially cheaper, unlimited supply

---

### How to Find Clinical Trials

**ClinicalTrials.gov**:

- Search "Alpha-1 Antitrypsin Deficiency"
- Filter by location, status

**Alpha-1 Foundation**:

- Website lists current AATD trials
- Call 1-877-228-7321 for information

**Mark Egly Foundation**:

- Updates on emerging treatments
- Help connecting with trials

**Ask your doctor**: "Are there clinical trials I might be eligible for?"

---

## Treatment Decision Guide

### Choosing the Right Treatment

**Factors to consider**:

- Genotype (ZZ, SZ, MZ)
- Lung function (FEV1)
- Symptoms (shortness of breath, cough)
- Liver involvement
- Age and overall health
- Smoking status
- Insurance coverage
- Personal preferences

---

### Treatment Algorithm

**ZZ Genotype + Lung Disease (FEV1 <80%)**:

- ‚úÖ Augmentation therapy
- ‚úÖ COPD medications (bronchodilators, ICS)
- ‚úÖ Pulmonary rehabilitation
- ‚úÖ Smoking cessation (if applicable)
- ‚úÖ Vaccinations
- ‚úÖ Regular monitoring
- Consider: Oxygen (if needed), lung transplant (if very severe)

**ZZ Genotype + No Lung Disease (FEV1 ‚â•80%)**:

- Discuss augmentation therapy (preventive use, not FDA-approved but some doctors recommend)
- ‚úÖ Smoking cessation/avoidance
- ‚úÖ Vaccinations
- ‚úÖ Regular monitoring
- Focus on prevention

**SZ Genotype + Lung Disease**:

- Discuss augmentation therapy (case-by-case)
- ‚úÖ COPD medications
- ‚úÖ Pulmonary rehabilitation
- ‚úÖ Smoking cessation
- ‚úÖ Vaccinations
- ‚úÖ Monitoring

**MZ/MS Genotype (Carrier)**:

- Usually no AATD-specific treatment
- If COPD symptoms: Standard COPD management
- ‚úÖ DO NOT SMOKE
- ‚úÖ Vaccinations
- ‚úÖ Monitoring

**Liver Disease (Any Genotype)**:

- See hepatologist
- Manage underlying causes
- Avoid alcohol, hepatotoxic drugs
- Monitor for cirrhosis/cancer
- Consider liver transplant (if severe)

---

## Insurance & Financial Assistance

### Insurance Coverage

**Most insurance covers AATD treatment**:

- Augmentation therapy (with prior authorization)
- Medications and inhalers
- Doctor visits and tests
- Oxygen therapy
- Pulmonary rehabilitation
- Transplantation

**Prior authorization**:

- Required for expensive treatments (augmentation therapy)
- Doctor submits medical records, test results
- Takes 2-4 weeks
- If denied ‚Üí appeal

---

### Financial Assistance Programs

**1. Co-Pay Assistance (for insured patients)**:

- **Grifols AlphaID**: 1-888-825-7421
- **CSL Behring**: 1-800-504-5434
- **Takeda**: 1-877-825-3327
- Covers co-pays, deductibles for augmentation therapy

**2. Patient Assistance Programs (for uninsured/underinsured)**:

- Free or reduced-cost augmentation therapy
- Each manufacturer has program
- Apply through specialty pharmacy or doctor

**3. Mark Egly Foundation Grants**:

- Financial assistance for testing, treatment, travel
- Apply at MarkEglyFoundation.org/grants

**4. Other Organizations**:

- **AlphaNet**: Free disease management (care coordinators, educational materials)
- **HealthWell Foundation**: Co-pay assistance
- **Patient Advocate Foundation**: Co-pay relief

**5. Medicare Extra Help**:

- If on Medicare and low income
- Helps with prescription drug costs

**Don't let cost prevent treatment**: Help is available

---

## Summary: Your Treatment Options

**AATD is treatable**:

- Augmentation therapy slows lung disease
- COPD medications relieve symptoms
- Lifestyle changes make huge impact
- Transplantation available for advanced disease
- New treatments coming (gene therapy, inhaled AAT)

**Key takeaways**:

- ‚úÖ Work with AATD specialist to create personalized treatment plan
- ‚úÖ Start augmentation therapy if candidate
- ‚úÖ Use COPD medications as prescribed
- ‚úÖ DO NOT SMOKE
- ‚úÖ Exercise regularly
- ‚úÖ Get vaccinated
- ‚úÖ Attend pulmonary rehab
- ‚úÖ Monitor lung function regularly
- ‚úÖ Connect with support
- ‚úÖ Don't let cost deter you (financial help available)

**You have options. Treatment works. You can live well with AATD.**

---

**Questions About Treatment?**

**Mark Egly Foundation**
üìû Phone: [TBD]
üìß Email: patients@markeglyfoundation.org
üåê Website: MarkEglyFoundation.org

**For Augmentation Therapy Info**:

- Grifols AlphaID: 1-888-825-7421
- CSL Behring: 1-800-504-5434
- Takeda: 1-877-825-3327

**For Clinical Trials**:

- ClinicalTrials.gov
- Alpha-1 Foundation: 1-877-228-7321

---

**Approved by**: Mark Egly Foundation Medical Advisory Board
**Effective Date**: November 7, 2025
**Review Date**: Annually
**Version**: 1.0

---

_"Treatment works. Early treatment works better. Don't wait."_

**‚Äî Mark Egly Foundation**
